title: Is ERK activation a good biomarker for estradiol and tamoxifen effects?
authors.affiliation: Wistar Institute, Philadelphia, Pennsylvania, USA.
authors.forename: Keiran S M
authors.initials: KS
authors.lastname: Smalley
authors.forename: Keith T
authors.initials: KT
authors.lastname: Flaherty
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D004789:Enzyme Activation; D004958:Estradiol / Q000494:pharmacology* / Q000627:therapeutic use; D048049:Extracellular Signal-Regulated MAP Kinases / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D013629:Tamoxifen / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015415:Biomarkers; D013629:Tamoxifen; D004958:Estradiol; D048049:Extracellular Signal-Regulated MAP Kinases